BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10220530)

  • 21. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of cholelithiasis].
    Mansurov KhKh
    Klin Med (Mosk); 1985 Jan; 63(1):10-6. PubMed ID: 2985865
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 25. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
    Zak RA; Marks JW; Schoenfield LJ
    Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
    [No Abstract]   [Full Text] [Related]  

  • 26. Bile salts: their role in cholesterol synthesis, secretion and lithogenesis.
    Brandt LJ; Bernstein LH
    Am J Gastroenterol; 1976 Jan; 65(1):17-30. PubMed ID: 1274926
    [No Abstract]   [Full Text] [Related]  

  • 27. Gallstone formation and dissolution.
    Coyne MJ; Schoenfield LJ
    Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gallstone dissolution].
    Leuschner U
    Internist (Berl); 1980 Oct; 21(10):607-16. PubMed ID: 7005153
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
    Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
    Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution.
    Northfield TC; Larusso NF; Thistle JL; Hofmann AF
    Gut; 1973 Oct; 14(10):826-7. PubMed ID: 4758693
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathophysiology and pharmacotherapy of cholelithiasis.
    Roda E; Aldini R; Bazzoli F; Festi D; Mazzella G; Roda A
    Pharmacol Ther; 1992; 53(2):167-85. PubMed ID: 1641404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiological aspects of cholelithiasis].
    Paumgartner G
    Z Gastroenterol Verh; 1976; (9):16-9. PubMed ID: 64077
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis and therapy of cholesterol gallstones: with emphasis on the metabolic effects of chenodeoxycholic acid.
    Conley DR; Goldstein LI
    Med Clin North Am; 1975 Jul; 59(4):1025-33. PubMed ID: 1142861
    [No Abstract]   [Full Text] [Related]  

  • 36. The medical treatment of gallstones.
    Bouchier IA
    Annu Rev Med; 1980; 31():59-77. PubMed ID: 6994627
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lithogenic bile].
    Frenkel M
    Ned Tijdschr Geneeskd; 1974 Dec; 118(51):1939-45. PubMed ID: 4612386
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of gallstones: implications for management.
    Duane WC
    Hosp Pract (Off Ed); 1990 Mar; 25(3):65-76, 79-80. PubMed ID: 2107192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The medical treatment of cholesterol gallstones. A major advance in preventive gastroenterology.
    Hofmann AF
    Am J Med; 1980 Jul; 69(1):4-7. PubMed ID: 7386506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.